“The single-minded pursuit of 'access at affordable prices' by the Government and the complete disregard for the promotion, development and growth of the industry will have a major adverse impact on the growth and sustainability of Indian pharmaceutical industry in 2018,” says DG Shah of the Indian ...
Read more: Pharma landscape '18: Watch out for the 'black swan'